Cargando…

Probiotics in the Treatment of Colorectal Cancer

The human microbiome plays many roles in inflammation, drug metabolism, and even the development of cancer that we are only beginning to understand. Colorectal cancer has been a focus for study in this field as its pathogenesis and its response to treatment have both been linked to the functioning o...

Descripción completa

Detalles Bibliográficos
Autores principales: Hendler, Robert, Zhang, Yue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6164107/
https://www.ncbi.nlm.nih.gov/pubmed/30205429
http://dx.doi.org/10.3390/medicines5030101
_version_ 1783359521438040064
author Hendler, Robert
Zhang, Yue
author_facet Hendler, Robert
Zhang, Yue
author_sort Hendler, Robert
collection PubMed
description The human microbiome plays many roles in inflammation, drug metabolism, and even the development of cancer that we are only beginning to understand. Colorectal cancer has been a focus for study in this field as its pathogenesis and its response to treatment have both been linked to the functioning of microbiota. This literature review evaluates the animal and human studies that have explored this relationship. By manipulating the microbiome with interventions such as probiotic administration, we may be able to reduce colorectal cancer risk and improve the safety and effectiveness of cancer therapy even though additional clinical research is still necessary.
format Online
Article
Text
id pubmed-6164107
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-61641072018-10-10 Probiotics in the Treatment of Colorectal Cancer Hendler, Robert Zhang, Yue Medicines (Basel) Review The human microbiome plays many roles in inflammation, drug metabolism, and even the development of cancer that we are only beginning to understand. Colorectal cancer has been a focus for study in this field as its pathogenesis and its response to treatment have both been linked to the functioning of microbiota. This literature review evaluates the animal and human studies that have explored this relationship. By manipulating the microbiome with interventions such as probiotic administration, we may be able to reduce colorectal cancer risk and improve the safety and effectiveness of cancer therapy even though additional clinical research is still necessary. MDPI 2018-09-07 /pmc/articles/PMC6164107/ /pubmed/30205429 http://dx.doi.org/10.3390/medicines5030101 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Hendler, Robert
Zhang, Yue
Probiotics in the Treatment of Colorectal Cancer
title Probiotics in the Treatment of Colorectal Cancer
title_full Probiotics in the Treatment of Colorectal Cancer
title_fullStr Probiotics in the Treatment of Colorectal Cancer
title_full_unstemmed Probiotics in the Treatment of Colorectal Cancer
title_short Probiotics in the Treatment of Colorectal Cancer
title_sort probiotics in the treatment of colorectal cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6164107/
https://www.ncbi.nlm.nih.gov/pubmed/30205429
http://dx.doi.org/10.3390/medicines5030101
work_keys_str_mv AT hendlerrobert probioticsinthetreatmentofcolorectalcancer
AT zhangyue probioticsinthetreatmentofcolorectalcancer